All In Biotech

Free tool

FAERS Monitor: Praxbind

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761025 or its brand name (Praxbind, Idarucizumab). Reports on generic versions are filed under their own applications.

Reports

1,434

Serious

1,398

97% of reports

Hospitalization

517

Death reported

899

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death170
  • haemorrhage119
  • gastrointestinal haemorrhage81
  • cerebral haemorrhage80
  • haemorrhage intracranial67
  • drug ineffective64
  • multiple organ dysfunction syndrome62
  • acute kidney injury48
  • sepsis46
  • ischaemic stroke45
  • pneumonia41
  • shock haemorrhagic41
  • cerebrovascular accident34
  • septic shock33
  • cardiac failure31

Reports by year received

View as table
YearReports
20156
2016114
2017207
2018309
2019274
2020167
2021140
202271
202369
202440
202524
202613

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,725 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
shock haemorrhagicSignal4174.254.92,876
haemorrhage intracranialSignal6766.052.24,210
ischaemic strokeSignal4537.127.81,541
cerebral haemorrhageSignal8032.826.52,437
multiple organ dysfunction syndromeSignal6232.225.21,840
haemorrhageSignal11916.714.11,749
gastrointestinal haemorrhageSignal8114.211.5986
septic shockSignal3311.17.9295
sepsisSignal466.14.6190
cardiac failureSignal315.74.0115
acute kidney injurySignal484.63.5133
cerebrovascular accidentSignal342.92.142
deathSignal1702.92.5218
pneumonia411.91.416
drug ineffective640.70.68

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.